Aeterna Zentaris
AEZS
#10313
Rank
A$25.29 M
Marketcap
A$8.26
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): A-$3.11

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is A-$2.96. In 2022 the company made an earnings per share (EPS) of A-$6.76 a decrease over its 2021 EPS that were of A-$2.63.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)A-$3.11
2022A-$6.76157.14%
2021A-$2.63-41.48%
2020A-$4.49-64.46%
2019A-$12.64-240%
2018A$9.03-122.32%
2017A-$40.43-53.53%
2016A-$87.01-86.71%
2015A-$654.89-35.21%
2014A-$1,011-216.67%
2013A$866.45-123.3%
2012A-$3,719-40.8%
2011A-$6,282-6.45%
2010A-$6,715-27.91%
2009A-$9,314-61.61%
2008A-$24,26183.61%
2007A-$13,213-195.31%
2006A$13,863178.26%
2005A$4,982-330%
2004A-$2,166-80.05%
2003A-$10,85817.78%
2002A-$9,219515.93%
2001A-$1,497-68.6%
2000A-$4,767119.62%
1999A-$2,171-3.63%
1998A-$2,252

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
A$10.40-451.41%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$2.98-200.79%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$5.00-268.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.52-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
A$3.77-227.38%๐Ÿ‡บ๐Ÿ‡ธ USA